OPY vs TMO · P/E 13, rev $1.43B vs P/E 24, rev $44.56B
Oppenheimer Holdings Inc (OPY) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Oppenheimer Holdings Inc (OPY) is a capital markets company listed on NYSE.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported OPY revenue for 2024-12-31 was $1.43B. Net income was $71.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
OPY currently screens at market cap $1.15B and trailing P/E 12.8. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the OPY and TMO stock pages for the full models.
Not investment advice.